Moderna's Splashy Biotech IPO Fizzles as Stock Sinks on Day One

(Bloomberg) -- Moderna Inc. shares sank on their first day of trading as investors gave a chilly reception to one of this year’s splashiest stock-market debuts.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.